TABLE 4.
Multivariate adjusted means for biochemical markers of bone, inflammation, and insulin across tertiles of plant‐based diet indices
|
All Mean ± SD |
Tertiles of PDI | p * | p † | |||
|---|---|---|---|---|---|---|
| Tertile1 | Tertile2 | Tertile3 | ||||
| Osteocalcin (ng/ml) | 20.5 ± 14.5 | 21.6 ± 15.0 | 19.9 ± 14.3 | 20.0 ± 14.5 | .57 | .51 |
| uCTX‐I (ng/ml) | 32.5 ± 7.30 | 32.7 ± 8.65 | 31.7 ± 7.08 | 32.5 ± 7.30 | .89 | .26 |
| PTH (ng/L) | 50.7 ± 27.1 | 56.6 ± 34.3 | 51.6 ± 26.9 | 45.1 ± 18.6 | .02 | .03 |
| hs‐CRP (mg/L) | 4.88 ± 13.9 | 3.84 ± 3.88 | 7.54 ± 23.4 | 3.27 ± 3.24 | .82 | .57 |
| 25(OH)D (ng/ml) | 11.0 ± 6.77 | 11.4 ± 6.40 | 10.5 ± 6.57 | 11.0 ± 7.30 | .70 | .88 |
| HOMA_IR | 3.78 ± 5.48 | 3.88 ± 7.26 | 2.67 ± 2.32 | 4.75 ± 5.69 | .39 | .22 |
| Insulin (µlu/ml) | 13.6 ± 14.5 | 12.1 ± 11.6 | 10.4 ± 9.81 | 18.0 ± 19.1 | .03 | .02 |
| Quicki | 0.34 ± 0.04 | 0.34 ± 0.04 | 0.35 ± 0.04 | 0.33 ± 0.04 | .16 | .45 |
|
All Mean ± SD |
Tertiles of hPDI | p * | p † | |||
|---|---|---|---|---|---|---|
|
Tertile1 |
Tertile2 | Tertile3 | ||||
| Osteocalcin (ng/ml) | 20.5 ± 14.5 | 21.7 ± 16.0 | 20.7 ± 16.6 | 19.1 ± 10.4 | .33 | .72 |
| uCTX‐I (ng/ml) | 32.3 ± 7.64 | 31.7 ± 7.01 | 32.0 ± 8.65 | 33.1 ± 7.26 | .30 | .33 |
| PTH (ng/L) | 50.7 ± 27.1 | 49.6 ± 21.5 | 53.1 ± 27.7 | 49.5 ± 31.4 | .98 | .65 |
| hs‐CRP (mg/L) | 4.88 ± 13.9 | 4.91 ± 9.74 | 5.34 ± 21.8 | 4.41 ± 4.50 | .84 | .54 |
| 25(OH)D (ng/ml) | 11.0 ± 6.77 | 10.9 ± 6.46 | 11.1 ± 7.30 | 10.9 ± 6.64 | .94 | .86 |
| HOMA_IR | 3.78 ± 5.48 | 3.97 ± 3.94 | 3.18 ± 4.88 | 4.19 ± 7.21 | .83 | .57 |
| Insulin (µlu/ml) | 13.6 ± 14.5 | 15.2 ± 16.2 | 12.5 ± 15.3 | 13.1 ± 11.9 | .43 | .39 |
| Quicki | 0.34 ± 0.04 | 0.33 ± 0.04 | 0.35 ± 0.04 | 0.33 ± 0.04 | .92 | .03 |
|
All Mean ± SD |
Tertiles of uPDI | p * | p † | |||
|---|---|---|---|---|---|---|
|
Tertile1 |
Tertile2 | Tertile3 | ||||
| Osteocalcin (ng/ml) | 20.5 ± 14.5 | 27.5 ± 21.0 | 17.8 ± 9.50 | 16.5 ± 7.02 | <.001 | .01 |
| uCTX‐I (ng/ml) | 32.3 ± 7.64 | 32.0 ± 8.28 | 33.5 ± 7.83 | 31.2 ± 6.64 | .58 | .39 |
| PTH (ng/L) | 50.7 ± 27.1 | 58.9 ± 36.4 | 43.9 ± 19.0 | 50.5 ± 22.1 | .04 | .02 |
| hs‐CRP (mg/L) | 4.88 ± 13.9 | 6.15 ± 22.2 | 5.00 ± 9.54 | 3.50 ± 3.81 | .32 | .58 |
| 25(OH)D (ng/ml) | 11.0 ± 6.77 | 10.4 ± 6.48 | 12.0 ± 7.02 | 10.4 ± 6.74 | .94 | .79 |
| HOMA_IR | 3.78 ± 5.48 | 3.14 ± 4.51 | 3.16 ± 2.91 | 5.18 ± 8.01 | .05 | .12 |
| Insulin (µlu/ml) | 13.6 ± 14.5 | 10.7 ± 11.3 | 12.5 ± 12.0 | 17.9 ± 18.9 | .01 | .03 |
| Quicki | 0.34 ± 0.04 | 0.34 ± 0.04 | 0.34 ± 0.04 | 0.33 ± 0.04 | .24 | .76 |
p value less than .05 was considered significant.
Values are based on mean ± standard deviation.
Abbreviations: µlu/ml, micro international unit per milliliter; HOMA_IR, Homeostasis Model Assessment for Insulin Resistance; hs‐CRP, high sensitivity c‐reactive protein; mg/L, milligram per liter; ng/L, nanogram per liter; ng/mL, nanogram per milliliter; OH, hydroxyl;PTH, parathormone; QUICKI, Quantitative Insulin‐sensitivity Check Index; u‐CTx, urinary C‐terminal telopeptide of type I collagen.
P for trend.
P for trend adjusted for age, sex, smoking, marital status, Disease, physical activity, BMI and energy.